Its activity is implicated in Parkinson’s disease, Alzheimer’s disease and multiple sclerosis [35,36], and some evidence exists that PHACTR2 may influence the development of cancer [37,38]. This evidence concerns the gene PHACTR2 and early-onset autosomal dominant Alzheimer disease.